Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Dermalex is a brand of over-the-counter, steroid-free topical creams and gels developed by Omega Pharma for treating mild to moderate inflammatory skin conditions including psoriasis, eczema, atopic dermatitis, rosacea, and acne. It contains a proprietary blend of modified alumino-silicates (Magneolite), alkaline earth minerals, and emollients like white petrolatum, cetearyl alcohol, and squalane that form a protective barrier to normalize skin cell production, reduce inflammation, itching, scaling, redness, and swelling while restoring the skin barrier and supporting natural repair mechanisms. Clinically tested for efficacy in symptom relief, it is suitable for long-term use without corticosteroids and is applied topically up to three times daily, with variants like Dermalex Psoriasis, Eczema, Rosacea, Acne, and Scalp Psoriasis Gel tailored to specific conditions.[2][3][5][7][8][12][13][14]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Dermalex.